Grey matter atrophy associated with the progression of cognitive decline in Parkinson’s disease (PD)
Objective: To investigate the pattern of grey matter (GM) atrophy associated with cognitive decline in PD by use of voxel-based morphometry (VBM) analysis. Background: Loss…Attention and dopamine: Increased distractibility in Parkinson’s disease
Objective: To determine the interactions between dopamine, Working Memory(WM) and Attentional Control(AC) in Parkinson's disease(PD) patients. Background: WM impairment is common in PD. Studies have…Cognitive function and self-reported depressive symptoms in a population-based cohort to study non-motor-symptoms of Parkinson’s disease
Objective: To describe the relation of depressive symptoms with cognitive performance in our cohort at baseline and two-year follow-up. Background: Cognitive function (CF) is frequent…Impulse control disorder in Parkinson’s disease is not related to lower cognitive performance
Objective: To compare cognitive performance in patients with and without Impulse Control Disorders (ICD) according to MDS recommendations for Parkinson's disease (PD) Mild Cognitive Impairment…Is Apple Watch a new hope for patients with Parkinson’s disease?
Objective: To assess the capability of the smart watch (Apple Watch®) as a simple monitoring tool of motor fluctuation in patients with Parkinson's disease (PD).…Overlapping corticobasal syndromes: The many faces of the Armstrong criteria
Objective: To evaluate the prevalence and clinical presentation of corticobasal variants listed in the new Armstrong criteria, exploring their overlap with progressive supranuclear palsy (PSP),…Symptom progression in a large cohort of Parkinson’s disease cases in a clinical practice setting
Objective: To assess the temporal profile of motor and non-motor symptoms in Parkinson's disease. Background: Parkinson's disease is characterized by varying combinations of motor and…Multicenter report of clinical use of a non-motor symptom questionnaire for craniocervical dystonia: The DNMS quest
Objective: To validate a non motor symptom (NMS) questionnaire in patients with craniocervical dystonia (CCD). Background: We have reported the clinical use of a Dystonia…The dopamine agonist withdrawal syndrome rating scale (DAWS-RS): Initial development of a new non-motor scale
Objective: To describe the development of the dopamine agonist withdrawal syndrome (DAWS) rating scale (DAWS-RS), a new questionnaire designed to evaluate the symptoms, severity, and…Dosing of abobotulinumtoxinA and muscle selection in patients with simple patterns of cervical dystonia
Objective: To report international dosing practice for abobotulinumtoxinA (ABO) in a real-world pragmatic setting for the management of cervical dystonia (CD) with simple patterns. Background:…
- « Previous Page
- 1
- …
- 176
- 177
- 178
- 179
- 180
- …
- 207
- Next Page »